BioLine Rx Ltd (STU:YP2)
€ 2.28 +0.040 (+1.79%) Market Cap: 9.92 Mil Enterprise Value: 6.36 Mil PE Ratio: 9,999.00 PB Ratio: 0.79 GF Score: 25/100